Vaccitech, CR UK link up to develop NSCLC drug
Cancer Research UK will sponsor and manage a Phase I/IIa clinical trial of the drug in combination with current standard of care and first-line treatment
Read More
Tag: Vaccitech
UK startup developing flu jab attracts £20m investment
A UK startup spun out from Oxford University in 2016 currently working on a universal flu vaccine is being backed by Google parent company Alphabet.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
